Table 2 Adverse effects of treatment experienced by patients included in the study
Adverse effect | group T (n = 18) | group N (n = 17) | p |
|---|---|---|---|
Arthralgia | 7 (38.9%) | 1 (5.9%) | 0.041 |
Myalgia | 3 (16.7%) | 1 (5.9%) | 0.603 |
Persistent breakthrough bleeding | 0 (0.0%) | 2 (11.8%) | 0.229 |
Depression | 4 (22.2%) | 1 (5.9%) | 0.338 |
Insomnia | 3 (16.7%) | 0 (0.0%) | 0.229 |
Decreased libido | 4 (22.2%) | 2 (11.8%) | 0.658 |
Vaginal dryness | 3 (16.7%) | 0 (0.0%) | 0.229 |
Hot flushes | 4 (22.2%) | 0 (0.0%) | 0.104 |
Hair loss | 2 (11.1%) | 0 (0.0%) | 0.486 |
Headache | 2 (11.1%) | 0 (0.0%) | 0.486 |
Weight gain | 1 (5.6%) | 2 (11.8%) | 0.603 |
At least one adverse effect | 14 (77.8%) | 6 (35.3%) | 0.018 |